Molecular materials often contain disorder, and this disorder may contribute significantly to the relative free energies of different solid forms at ambient temperatures. In the context of pharmaceutical materials, disorder is generally perceived as a risk factor, as it is assumed to reflect metastability with respect to some fully ordered structure. Hence reducing disorder, e.g. via co-crystallisation, is generally perceived as desirable .